Employees value innovative technology initiatives and inclusive company culture Medidata is the only life science technology company on the list Company atmosphere and management transparency rank high on the list NEW YORK --(BUSINESS WIRE)--Jan. 18, 2019-- Great Place to Work and FORTUNE named
NEW YORK --(BUSINESS WIRE)--Jan. 7, 2019-- Medidata (NASDAQ:MDSO) today announced the addition of executive vice president of Digital and AI Solutions, Sastry Chilukuri to its senior leadership team. This press release features multimedia. View the full release here:
NEW YORK --(BUSINESS WIRE)--Dec. 27, 2018-- Medidata (NASDAQ:MDSO) today announced that Tarek Sherif , chairman and chief executive officer, and Rouven Bergmann , chief financial officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan.
Study leverages Medidata Rave EDC, Edge eTMF and Edge Payments Cala Health unifies data and streamlines payments and document management on the Medidata Cloud Medidata supports observational study of first-in-class non-invasive, targeted nerve stimulator for the treatment of Essential Tremor The
Sponsors, CROs, and Sites Retain and Easily Access End Of Study Media Necessary to Meet Regulatory Requirements Reduces Regulatory Burden through Automatic Event Triggers from Rave EDC to Edge RCM Edge RCM Automates and Simplifies Access to EOS Documents Eliminates Need to Distribute and Use CDs
Discovery of biomarker evidence in Castleman Disease exemplifies the value of personalized medicine in rare diseases The Castleman Disease Collaborative Network presented new research supported by Medidata at 60th Annual Meeting of the American Society of Hematology Application of Medidata Rave
Rave Engage Named Top Technology for Sponsors at 14th Annual Scrip Awards Medidata Wins Prestigious Industry Award for Third Consecutive Year Scrip Award Celebrates Innovation and Excellence in Biopharmaceutical Industry NEW YORK --(BUSINESS WIRE)--Nov.
NEW YORK --(BUSINESS WIRE)--Nov. 29, 2018-- The United States District Court for the Southern District of New York has rejected Veeva’s motion to dismiss Medidata’s complaint against Veeva for theft of trade secrets, the company announced today. “The Court’s decision allows us to continue with our
NEW YORK --(BUSINESS WIRE)--Nov. 21, 2018-- Medidata (NASDAQ:MDSO) today announced its participation in two upcoming investor conferences. Rouven Bergmann , chief financial officer, will present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, Nov.
Medidata Rave Omics Machine Learning Identifies New Evidence of Biomarkers in Rare Disease Research by the Castleman Disease Collaborative Network Memorial Sloan Kettering Cancer Center (MSK) Monitors Newly Diagnosed Myeloma Patients with Medidata ePRO NEW YORK --(BUSINESS WIRE)--Nov.